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Abstract High levels of plasma homocysteine are asso-
ciated with an increased risk of many health conditions
influenced by both environmental and genetic factors. The
objective of this study was to provide the geographical
distribution of folate pathway genetic polymorphisms in
Mexico and the comparison with the reported frequencies
in different continental populations. This study included
the analysis of the genotypic frequencies of eight poly-
morphisms in genes of the folate/homocysteine metabolic
pathway in 1,350 Mestizo and Amerindian subjects from
different regions in Mexico and 836 individuals from
European, African and Asian populations of the 1,000
Genomes Project. In Mexican Mestizo and Amerindian
populations, the MTHFR C677T risk genotype (TT) was
highly prevalent (frequency: 25 and 57 %, respectively). In
Mestizos, the frequency showed clear regional variation
related to ancestry; the Guerrero subpopulation with the
highest Amerindian contribution had the highest TT fre-
quency (33 %). The MTHFD1 G1958A AA risk genotype
was also enriched in Mexican Mestizos and Amerindians
(frequency: 34 and 58 %, respectively), whereas in African
and Asian ancestry populations the frequency for AA was
low (*4 %). All together risk genotypes showed
regional differences, and Sonora had significantly different
genetic frequencies compared with the other regions
(P value \0.05). Our study illustrates differential geo-
graphical distribution of the risk variants in the folate/
homocysteine metabolic pathway relative to ethnic back-
ground. This work supports that certain areas of the world
have increased needs for folic acid and vitamin B supple-
mentation, and this information needs to be considered in
public health guidelines and eventually policies.
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Introduction
Folates are a group of molecules that belong to the vitamin
B family, differing by their oxidation state, number of
glutamic acid moieties and one-carbon substitutions (For-
ges et al. 2007). They are part of the commonly known
folate-mediated one-carbon metabolism pathway, a system
consisting of a number of interdependent metabolic cycles,
that are necessary in a large number of biochemical
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processes, such as amino acid metabolism, purine and
pyrimidine synthesis and methylation of nucleic acids,
proteins and lipids (Forges et al. 2007; Carr et al. 2009).
The folate-mediated one-carbon metabolism pathway is
essential for human health and development, which is made
evident by the fact that folate deficiency has been linked to
a variety of conditions along the life span including adverse
pregnancy outcomes such as neural tubes defects (NTDs).
Hyperhomocysteinemia a known risk factor to a range of
conditions, such as cardiovascular and neurodegenerative
disorders, has also been associated with this metabolic
pathway (Forges et al. 2007). Folic acid supplementation
during the periconceptional period reduces greatly the risk
of NTDs (Prevention of neural tube defects: results of the
Medical Research Council Vitamin Study. MRC Vitamin
Study Research Group 1991), and many countries have
now mandatory fortification legislation and programs in
place to avert the disease risks linked to folate deficiencies
(Wolff et al. 2009; Berry et al. 1999). In Latin America,
following the implementation of folic acid fortification,
NTDs prevalence was decreased from 33 to 59 % (Ro-
senthal et al. 2013). However, the benefit of folic acid
supplementation in reducing the risk for cardiovascular
diseases (CVD) by decreasing the homocysteine levels is
not clear, revealing a more complex relationship between
vitamin intake levels, homocysteine and CVD (Bonaa et al.
2006; Homocysteine Studies 2002; Toole et al. 2004; Lonn
et al. 2006).
Several studies have identified associations between
polymorphisms in genes related to the folate pathway
(Fig. 1), some of them with known functional implications,
and specific conditions, including NTDs, CVD, psychiatric
disorders and some types of cancers, such as colorectal,
pancreatic, gastric and ovarian (Berry et al. 1999; Greene
et al. 2009; Gueant-Rodriguez et al. 2006; Fredriksen et al.
2007; Koushik et al. 2006; Lissowska et al. 2007). How-
ever, there is evidence that shows no effects or conflicting
findings about these associations of genetic variants of
folate metabolism (Ding et al. 2013; Stevens et al. 2008;
Sharp and Little 2004; Zhou et al. 2012; Yu et al. 2010).
One problem in the meta-analyses of genetic association
studies is the scarcity of data sets that would allow for the
analysis of covariates (Jennings and Willis 2014); conse-
quently, the metabolic effects associated with altered one-
carbon metabolism of these diseases require extensive
investigations.
In relation to polymorphisms in genes functionally
related to this pathway, as of today, only some have been
analyzed in case–control and/or in epidemiological studies
in different populations. Some of these extensively stud-
ied are within the methylenetetrahydrofolate reductase
gene (MTHFR), which encodes for an enzyme catalyzing
the irreversible reduction of 5, 10-methylenetetrahydrof-
olate to 5-methyltetrahydrofolate serving as the methyl
donor for the vitamin-B12-dependent remethylation of
homocysteine (Hcy) to methionine (Fig. 1) (Frosst et al.
1995). These polymorphisms are the MTHFR C677T
(A222V, rs1801133) and A1298C (E429A, rs1801131),
both known to result in a decreased activity of the
enzyme (Frosst et al. 1995; Weisberg et al. 1998). In
addition to these functional polymorphisms, other genetic
variants within coding regions of related genes in this
pathway have been found to be associated with a variety
of complex traits and disorders, including the methionine
Fig. 1 Metabolic cycle of
homocysteine, the seven
enzymes carrying the functional
SNPs analyzed in the study are
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synthase reductase MTRR A66G, the methionine synthase
or 5-methyltetrahydrofolate-homocysteine methyltransfer-
ase MTR A2756G, the methylenetetrahydrofolate dehy-
drogenase 1 MTHFD1 G1958A, the folate hydrolase
FOLH1 T484C, the solute carrier family 19 (folate influx
transporter) member 1 SLC19A1 A80G and the transport
protein of vitamin B12, transcobalamin II TCN2 C776G
(Gaughan et al. 2001; Lissowska et al. 2007; Silva et al.
2011; Guo et al. 2013; Xie et al. 2012; Dervieux et al.
2004b; Laverdiere et al. 2002; Martinelli et al. 2006;
Moskau et al. 2007; Parveen et al. 2013). The frequencies
of some of these polymorphisms are known to vary across
different geographical regions and ethnic groups. For
example, the MTHFR 677TT genotype frequency is often
reported to be high in European, Asian, Central and South
American (10–32 %), low in different African populations
(0–3 %) (Wilcken et al. 2003) and also showing geo-
graphical gradients among Chinese Han populations
(Yang et al. 2013). The possibility of having accurate
information about the frequency of these polymorphisms
and better understanding of their variation between and
within populations can help experts in this field improve
the design of association studies, aid in the evaluation of
regional dietary requirements and inform public health
policy makers.
The Mexican population is mainly composed by Mes-
tizos, who are individuals with a genetic background
consisting of Amerindian, European and, to a lesser extent,
African ancestries, and as a result of admixture, the
resulting linkage disequilibrium patterns in all these
genetic loci may affect the allele frequencies (Silva-Zo-
lezzi et al. 2009). This population has been reported to have
one of the highest frequencies of the MTHFR 677T allele
worldwide, above to that reported in some European and
African populations (Wilcken et al. 2003), suggesting that
this results due to an enrichment of this variant in Mexicans
through the admixture process and the Amerindian ances-
tral contribution. To better understand the distribution of
this and other variants in the folate-mediated one-carbon
metabolism pathway in a highly admixed population such
as Mexicans, we describe and compare the allele and
genotype frequencies of FOLH1 T484C, MTR A2756G,
MTHFD1 G1958A, MTRR A66G, MTHFR A1298C,
MTHFR C677T, SLC19A1 A80G and TCN2 C77G (Fig. 1;
Suppl. Table 1) in 1,104 Mexican Mestizos from the
Mexican Genome Diversity Project (MGDP), 246 subjects
with Amerindian ancestry and 836 samples from Phase I,
1,000 Genomes Project, from distinct continental locations,




DNA samples included in this study are from 1,104 adult
Mexican Mestizos (MEX) from the Mexican Genome
Diversity Project (MGDP) (Silva-Zolezzi et al. 2009),
corresponding to 184 unrelated individuals (92 males and
92 females) from each of six different states of Mexico:
Sonora (SON), Guanajuato (GUA), Zacatecas (ZAC),
Guerrero (GUE), Veracruz (VER) and Yucatan (YUC). In
addition, we included samples from three Amerindian
groups (AMI), 172 Nahuas (NAH), 49 Zapotecos (ZAP)
and 25 Totonacas (TOT) (Fig. 2). All individuals in the
Amerindian groups, their parents and grandparents recog-
nized themselves as indigenous, had been born and lived in
their home communities and spoke their native language.
This study was conducted according to the principles
expressed in the Declaration of Helsinki. All the partici-
pants of the MGDP and the Amerindian groups signed a
consent approved by the Scientific, Ethics and Biosafety
Review Boards from the National Institute of Genomic
Medicine (INMEGEN) and the National Institute of Med-
ical Sciences and Nutrition Salvador Zubira´n (INCMNSZ),
respectively. The genotypic and allelic frequencies analysis
of this study was approved by the Ethics committee as
previously reported (Contreras et al. 2014; Silva-Zolezzi
et al. 2009; Leon-Mimila et al. 2013). No phenotypic data
of the subjects were available or analyzed. DNA was iso-
lated from buffy coats obtained from blood using the
QIAamp DNA Blood Maxi Kit (Qiagen GmbH, Hilden,
Germany).
Genotyping
We analyzed eight SNPs, MTHFR C677T and A1298C,
MTR A2756G, MTRR A66G, MTHFD1 G1958A, TCN2
C776G, FOLH1 T484C and SLC19A1 A80G, by allelic
discrimination with TaqMan SNP genotyping assays
(Applied Biosystems, Life Technologies CA, USA),
according to the manufacturer’s protocol. We used 15 ng
of genomic DNA as template, the assays run on 7900HT
PCR Real Time System (Applied Biosystems, Life Tech-
nologies CA, USA) and then analyzed using the Sequence
Detection System v2.2.2. To verify the accuracy of the
genotyping, we compared our data with the genotypes for
all SNPs, except MTRR A66G, obtained for a subset of 296
individuals from the Mexican Mestizos group by using
Illumina 550 K (Moreno-Estrada et al. 2014) and 510 K
arrays (Illumina Inc., CA, USA).
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Genotype data from public databases
Individual genotype data, publicly available, from East
Asian (ASIA), African (AFR) and European (EUR) par-
ticipants in the 1000 Genomes Project, Phase I were
retrieved from www.1000genomes.org. From East Asia, 97
Han Chinese from Beijing, 89 Japanese from Tokyo and
100 Southern Han Chinese were included. The African
population consisted of 97 Luhya from Webuye, Kenya
and 88 Yoruba from Ibadan, Nigeria. Finally, the European
population included 89 British from England and Scotland,
93 Finnish, 98 Toscani from Italy and 85 Utah residents
with Northern and Western European ancestry. Detailed
information on the projects and the recruited subjects can
be found in www.1000genomes.org (Genomes Project
et al. 2010). For MTHFR C677T, genotyping data were
retrieved in August 2013 from the ALlele FREquency
Database http://alfred.med.yale.edu/alfred/index.asp and
were used to visualize the world distribution of the risk
genotype (Rajeevan et al. 2012).
Statistical analysis
Allele and genotype frequencies were calculated by direct
counting (Griffiths et al. 2000). Deviations from Hardy–
Weinberg equilibrium (P \ 0.005) and comparison of
allele or genotype frequencies between different popula-
tions were tested with Fisher’s exact test. Calculated con-
fidence intervals (95 %) around a completion rate were
constructed in SPSS. Genotype distributions in different
populations were compared using Kruskal–Wallis test. All
maps were constructed using the MapPoint software
(Microsoft MapPoint, version 2010).
Results
All SNPs in the Mexican Mestizos (MEX) had call rates
[95 %, and in the Amerindians (AMI) samples, three
genotyping assays (MTHFD1 G1958A, MTHFR A1298C,
MTR A2756G) had a call rate of [97 % and five assays
(MTHFR C677T, MTRR A66G, SLC19A1 A80G, TCN2
C77G) had a call rate of 89 % (Supp. Table 1). For all
SNPs, genotypic frequencies were in accordance with
Hardy–Weinberg Equilibrium (P [ 0.005). The concor-
dance between our frequency genotyping data obtained by
allelic discrimination with TaqMan, and those acquired
from the Mexican Genome Diversity Project using Illu-
mina 510 and 550 K arrays was high (=99.43 %).
Geographical distribution of folate-mediated one-
carbon metabolism pathway alleles and genotypes
showing continental differences but not major intra-
population differences in Mexican Mestizos
Four of the eight variants analyzed, FOLH1 T484C, TCN2
C77G, SLC19A1 A80G and MTR A2756G, showed a
similar average frequency distribution between MEX, AMI
and EUR groups (MAF frequencies: 23–26, 31–43, 54–58
and 17–25 %, respectively), which correlates with either
Fig. 2 Geographical distribution of the Mestizos (MEX) and the three Amerindian (AMI) Mexican populations included in the study
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no significant differences or very low variation in their
frequency within MEX groups (Figs. 3, 4, 5, 6).
The risk genotype (CC) for FOLH1 T484C had a fre-
quency B14 % in all Mexican groups (MEX, NAH, ZAP
and TOT). EUR and ASIA had a CC frequency of 6 % and
of 13 %, respectively. The highest CC frequency was
observed in the AFR group (34 %) (Supp. Table 2; Fig. 3).
The risk genotype (GG) for TCN2 C77G ranged from 8 to
18 % in all Mexican populations (MEX and AMI), exclud-
ing TOT in which the GG genotype was absent. The fre-
quency of the GG genotype was higher in EUR (20 %) and
ASIA (29 %) than in AFR (6 %), where it had the lowest
frequency of all continental groups (Supp. Table 3; Fig. 4).
The risk genotype (GG) for SLC19A1 A80G had a high
frequency in MEX, AMI and EUR populations, ranging
from 25 % in ZAP to 38 % in VER (Supp. Table 4;
Fig. 5). ASIA had 21 % of the GG genotype and AFR
showed the lowest frequency (9 %) (Supp. Table 4;
Fig. 5).
Finally, the risk genotype (GG) for MTR A2756G was
B11 % in most populations included (Supp. Table 5;
Fig. 6). EUR populations and MEX populations with high
European ancestry, SON and GUE had the lowest fre-
quencies for the MTR A2756G (B2 %). In ZAP, there was
no carrier of the MTR A2756G GG genotype. AFR had the
highest frequency of the GG genotype for this SNP (11 %).
Geographical distribution of folate-mediated one-
carbon metabolism pathway alleles and genotypes
showing continental variation and intra-population
differences in Mexican Mestizos
In contrast to the additional four out of the eight variants
analyzed, MTRR A66G, MTHFR C677T, A1298AC and
Fig. 3 a Comparative frequency of the homozygotes for the risk allele
of FOLH T484C in the studied populations (*P value [0.0001
and\0.05, **P value \0.0001 for significant differences in genotype
frequencies), b minor allele frequency of FOLH T484C in six Mexican
Mestizo groups
Fig. 4 a Comparative frequency of the risk allele homozygotes for TCN2 C77G in the studied populations (*P value [0.0001 and \0.05,
**P value \0.0001 for significant differences in genotype frequencies), b minor allele frequency of TCN2 C77G in six Mexican Mestizo groups
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MTHFD1 G1958A showed a gradient in the frequency
between MEX groups and highly significant differences
between AMI and EUR groups (P values \10-4).
The risk genotype (GG) for MTRR A66G presented the
highest frequency in EUR (33 %), deviating from ASIA,
AFR, AMI and MEX (Supp. Table 6; Fig. 7). Among
MEX, the group with the highest European ancestry (SON)
had the highest frequency of GG genotype carriers (Fig. 7).
In EUR, we observed a North-to-South gradient in the GG
genotype frequencies, with Finnish having the highest
frequency (44 %), followed by British (32 %) and Italians
having the lowest of the three (19 %) (data not shown).
The risk genotype (CC) for the MTHFR A1298C pre-
sented a similar distribution as for MTRR A66G. Overall,
the frequency of CC genotype was B11 %, and EUR and
SON within the MEX groups had the highest frequencies,
11 and 7 %, respectively (Supp. Table 7; Fig. 8). In con-
trast to MTRR A66G, European populations from the 1,000
GP had similar risk genotypes frequencies for MTHFR
A1298C (data not shown).
In MTHFR C677T, homozygotes for the risk T allele were
found in very high frequency in all three AMI groups included
in the study. NAH and ZAP had a frequency of subjects with a
TT genotype of 59 and 62 %, whereas in TOT 36 % had a TT
genotype (Supp. Table 8; Fig. 9). In AFR populations, there
was no TT genotype, whereas ASIA and EUR had a 15 and
13 %, respectively. In the MEX groups, the TT frequency
ranged from 17 % in SON to 33 % in GUE. The risk allele had
an average frequency of 50 % frequency in MEX (Supp.
Table 8; Fig. 9). Genotyping data for MTHFR C677T
retrieved from ALFRED database (including studies by Botto
et al., Wilcken et al. and Yang et al.) revealed a similar world
Fig. 5 a Comparative frequency of the risk allele homozygotes for
SLC19A1 A80G in the studied populations (*P value [0.0001
and\0.05, **P value \0.0001 for significant differences in genotype
frequencies), b minor allele frequency of SLC19A1 A80G in the six
Mexican Mestizo Groups
Fig. 6 a Comparative frequency of the risk allele homozygotes for
MTR A2756G in the studied populations (*P value [0.0001
and\0.05, **P value \0.0001 for significant differences in genotype
frequencies), b minor allele frequency of MTR A2756G in six
Mexican Mestizo groups
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distribution to that of the 1,000 GP populations we included in
our study (Botto and Yang 2000; Wilcken et al. 2003; Yang
et al. 2013), excepting China which presented a lower fre-
quency in 1000GP population that the one of previous pub-
lications (Fig. 10) (Yang et al. 2013).
The risk genotype (AA) for MTHFD1 G1958A was
found more frequent in all AMI (55–65 %), whereas in
ASIA and AFR the frequency was low (4 %). EUR and
SON had similar frequency, 19 and 21 %, respectively
(Supp. Table 9). The rest of the MEX and AMI have an
intermediate distribution of the homozygous carriers for
the risk allele ranging from 35 to 39 %, with SON differing
significantly (P value \0.0001) from the rest (Fig. 11).
Gender differences in the genotypes distribution
in Mexican Mestizos
We examined whether the genotypes distribution for the
eight SNPs were significantly different between males
and females in the MEX populations. We only found a
significant difference in the genotype distribution
between genders for FOLH1 T484C (P = 0.0006). In
women, MAF of FOLH1 T484C was higher than in men
(Suppl. Table 10; Suppl. Fig. 1). For SLC19A1 A80G,
MTHFD1 G1958A, MTHFR A1298C and MTR A2756G,
borderline significant differences were found (Suppl.
Table 1).
Fig. 7 a Comparative frequency of the risk allele homozygotes for MTRR A66C in the studied populations (*P value [0.0001 and \0.05,
**P value \0.0001 for significant differences in genotype frequencies), b minor allele frequency of MTRR A66C in six Mexican Mestizo groups
Fig. 8 a Comparative frequency of the risk allele homozygotes for
MTHFR A1298C in the studied populations (*P value [0.0001
and\0.05, **P value \0.0001 for significant differences in genotype
frequencies), b minor allele frequency of MTHFR A1298C in six
Mexican Mestizo groups
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Discussion
Our study investigated the distribution of eight disease
risk-associated alleles and genotypes of functional SNPs
within seven genes encoding for enzymes from the folate
pathway in both, admixed (MEX) and indigenous (AMI)
Mexican populations, and a comparative analysis was done
against their frequencies in samples from major continental
population groups: European (EUR), East Asian (ASIA)
and Africans (AFR).
Some risk genotypes frequencies were very similar
among and between MEX and AMI groups, including
FOLH1 T484C, TCN2 C77G and MTR A2756G. Of these,
TCN2 C77G showed continental differences, and FOLH1
T484C, MTR A2756G and SLC19A1 A80G had similar
frequencies in most populations analyzed, only showing a
significantly different frequency in AFR groups. In con-
trast, the risk genotypes for MTRR A66C, MTHFR
A1298C, MTHFR C677T and MTHFD1 G1958C variants
showed both continental and intra-population differences
in MEX and AMI groups (P \ 0.0001). In the three AMI
groups included in our study, no MTRR 66CC or MTHFR
1298CC genotypes were found, and a low frequency of the
risk allele for both was observed (MAF B 7 %). These risk
genotypes were more frequent in EUR (33 and 11 %,
respectively), and among the MEX groups had the highest
frequency in SON, in relation to the high European
ancestral contribution to this population group. The risk-
Fig. 9 a Comparative frequency of the risk allele homozygotes for
MTHFR C677T in the studied populations (*P value [0.0001
and\0.05, **P value \0.0001 for significant differences in genotype
frequencies), b minor allele frequency of MTHFR C677T in six
Mexican Mestizo groups
Fig. 10 Global distribution of
TT % for MTHFR C677T
(Source: ALFRED database)
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associated genotypes MTHFD1 1958AA and MTHFR
677TT had a particularly high frequency in the MEX
population, 34 and 25 %, respectively. The frequencies of
both SNPs in the AMI groups included in our study were
[55 %, supporting the hypothesis that this phenomenon is
related to the Amerindian ancestral contribution to the
admixture process (Wilcken et al. 2003; Davalos et al.
2000; Juarez-Velazquez et al. 2010). This is further sup-
ported by the observed gradient in the frequency of these
variants in the MEX populations analyzed, within which,
the highest and the lowest frequencies were observed in
GUE and SON, the groups with, respectively, the highest
and the lowest Amerindian ancestry contribution in this set
of samples (Silva-Zolezzi et al. 2009). Interestingly, for
these SNPs, the frequencies of the risk-associated genotype
were lower in ASIA and EUR populations (\20 %) and
almost absent in the AFR populations (B4 %), which
underlines the more specific relevance of these genetic
variants for populations with Amerindian ancestry, such as
most populations of central and south America, Native
American and most Hispanic groups living in the USA.
Our observed MTHFR C677T frequencies were similar
to those of populations with the same ancestry of the
1000GP or of previous reports (Davalos et al. 2000; Juarez-
Velazquez et al. 2010; Wilcken et al. 2003). Nevertheless,
we have provided a more detailed description of within
population differences that was not captured in any of the
previous studies. Our results are in agreement with a pre-
vious study investigating the prevalence of MTHFR 677TT
genotype in different regions in Mexico in which the
lowest frequency was observed in the north of the country
(in our study SON) and the highest frequency in the center
of the country (in our study GUE) (Mutchinick et al. 1999).
In the same study, Mutchinick et al. reported highly sig-
nificant differences of MTHFR 677TT genotype frequency
in Mexico compared with other countries, supporting that
the high prevalence of NTDs in Mexico may be related to
the particularly frequent presence of the non-functional T
allele in the population. Indeed, in Mexico, the highest
prevalence of NTDs in the world has been documented.
According to the data from the program of Registry and
Epidemiological Surveillance of External Congenital
Malformations (RYVEMCE), approximately one in 250
conceptions that reach 20 weeks of gestation or more
present a NTD. This number is three or four times higher
than that observed in populations from South America and
Spain (Mutchinick et al. 1988, 1999; Conjoined twins–an
epidemiological study based on 312 cases. The Interna-
tional Clearinghouse for Birth Defects Monitoring Systems
1991). The prevalence at birth for anencephaly and spina
bifida, the NTDs most frequently observed, was 18.4 and
15.6 per 10,000 births, respectively (Mutchinick et al.
1988, 1999). Interestingly, the state of Guerrero (GUE) has
shown a trend of significantly increased annual NTD
mortality rate per 10,000 living born infants since 1990
(Ramirez-Espitia et al. 2003).
The investigation of MTHFR 677TT in NTDs risk has
been well documented with studies showing a significant
association of the genotype with NTDs risk (Yan et al.
2012; Harisha et al. 2010; Grandone et al. 2006) and others
not supporting the association or revealing a complex
mechanism by which folate intake, parental and infant
genotype interplay (Johnson et al. 1999; Shaw et al. 1998;
Shields et al. 1999).
In this analysis, we observed that the 1000GP Han
Chinese population data MTHFR 677TT had a lower
Fig. 11 a Comparative frequency of the risk allele homozygotes for
MTHFD1 G1958A in the studied populations (*P value [0.0001 and
\0.05, **P value \0.0001 for significant differences in genotype
frequencies), b minor allele frequency of MTHFD1 G1958A in six
Mexican Mestizo groups
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frequency (15 %) compared with a large study recently
published and being included also in ALFRED, which
included[15,000 adults of Han nationality from 10 regions
in China (Yang et al. 2013). Older reports on the MTHFR
677TT have also reported lower frequencies compared
with Yang et al. (Wilcken et al. 2003). This may suggest
that important differences in the frequency distribution of
functional variants within populations can be more accu-
rately described when more comprehensive analyses are
done. Considering the relevance of the MTHFR C677T
polymorphism for public health, these results highlight the
potential need of more detailed studies in different popu-
lations to better understand the worldwide frequency dis-
tribution of this and also other clinically relevant variants.
Though a previous study has reported a decreased pro-
portion of MTHFR 677TT in female newborns (Rozen
et al. 1999), proposing that gender effects exist, our study
has not identified a large gender effect for any of the
studied variants, in accordance with the previous study in
the Han Chinese (Yang et al. 2013).
Our study provides evidence that functional variants
other than the MTHFR C677T and relevant to the folate-
mediated one-carbon metabolism are also specifically
enriched in populations, and this can be relevant for
informing public health policy but also supporting or
generating hypotheses related to their potential role in
selection processes. For example, the less studied FOLH1
T484C and TCN2 C77G risk variants were found more
abundant in AFR and ASIA populations, respectively
(Gueant et al. 2007), than in the rest of the populations
included in our study. Interestingly, both proteins are
involved in the intestinal absorption of factors (folate and
B12) with a pivotal role in the homocysteine metabolic
pathway and the functional variants are thought to impair
their function (Gueant et al. 2007; Guo et al. 2013). There
are direct associations of these SNPs with NTDs (Guo et al.
2013; Gueant-Rodriguez et al. 2003; Martinelli et al. 2006)
and autism (Martinelli et al. 2006). Plausible hypotheses
explaining their population distribution could be that they
may be part of the selective pressure process or providing a
survival advantage. As an example, in CC individuals for
the TCN2 C77G allele, tHcy levels seem to be more
responsive to dietary B12 or B12 supplementation (Garrod
et al. 2010); it has been also proposed that this polymor-
phism could influence the susceptibility to malaria, as
higher frequencies of the risk variant were observed in
patients with severe malaria (Gueant et al. 2007). FOLH1
T484C in our study presents almost an exclusively high
frequency in populations with an African ancestry; the
polymorphism has been associated with plasma folate
levels suggesting that genetic frequencies may be under
population-specific evolutionary mechanisms related to
folate bioavailability (DeVos et al. 2008).
MTHFR C677T has also been proposed to interact with
environmental factors to confer selective pressure; for
example, a correlation with ultraviolet radiation exposure
has been proposed, which is thought to partly explain the
North-to-South gradient of this risk variant gradient in
Europe (Yafei et al. 2012; Cordain and Hickey 2006). A
similar phenomenon may be related to the inverse gradient
observed for MTRR A66C for which higher frequencies of
MTRR 66C are found in northern Europe (44 % in Finland)
compared with southern Europe (19 % in Italy). In the case
of the MTHFR polymorphisms, several relevant gene–
nutrient interactions have been described, for example,
MTHFR 677T was proposed to confer a selective advan-
tage to populations with higher folate intake, such as south
Europeans and Mexicans (Gueant-Rodriguez et al. 2006),
and more recently, it was found to be associated with a
decrease of both serum folate and cell folate concentrations
and an altered mix of circulating folate forms (Farrell et al.
2013). A nutrigenetic association has been reported with
vitamin B2, a precursor of the flavino-adenine dinucleotide
(FAD) and a known cofactor of the MTHFR enzyme. In
this case, carriers of the TT genotype with suboptimal
dietary levels of vitamin B2 are benefited by the increased
intake of the vitamin improving substantially their tHcy
levels and blood pressure (Horigan et al. 2010; McNulty
et al. 2006; Wilson et al. 2012, 2013). An improved blood
pressure control for MTHFR 677TT genotype carriers
without being influenced by the type of antihypertensive
medication has been demonstrated in pre-hypertensive and
hypertensive individuals following B2 supplementation
(Wilson et al. 2012). In Mexico, high rates of increased
blood pressure have been recently documented with
*32 % of the population over 50 years of age having at
least stage I systolic hypertension and[47 % being at pre-
hypertensive levels (Cortes-Hernandez et al. 2014). Less
than 50 % of the populations in Mexico that are aware of
their increased blood pressure are estimated to control their
blood pressure through either medication or lifestyle
interventions (Prince et al. 2012; Basu and Millett 2013).
The described interactions between MTHFR C677T, diet-
related factors such as vitamin B2 and control of blood
pressure should be considered at least during dietary rec-
ommendations, particularly in populations like the Mexi-
can with a high frequency of this risk variant.
In addition to folate and other B vitamins, other dietary
factors need to be considered when evaluating the role of
the functional variants in the homocysteine metabolic
pathway. For example, choline status parameters are
influenced by the functional variant MTHFD1 G1958A,
when folate status is low (Ivanov et al. 2009). Carriers of
the risk variant were found to be in high risk of developing
choline deficiency on a low choline diet compared with
carriers of the wild-type variant, having thus an increased
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choline intake requirement (Kohlmeier et al. 2005). This is
particularly important for specific population groups, such
as pregnant women due to the proposed role of choline in
fetal brain development (Zeisel 2011). Mexican popula-
tions in our study have a highly enriched MTHFD1
1958AA frequency (*35 %) due to their Amerindian
ancestry, as shown in the Nahuas, Totonacas and Zapotecos
in our study presenting a MTHFD1 1958AA frequency of
*60 %. The need for choline dietary recommendations is
therefore more pronounced in these populations.
Finally, studying allelic variants in genes involved in
folate metabolism are useful and relevant not only for the
nutrigenetics field but also for pharmacogenetics. MTHFR
677T may be used to help identify patients with an
increased likelihood of methotrexate-related adverse events
(Urano et al. 2002; Evans 2002); SLC19A1 A80G has been
associated with decreased methotrexate therapeutic
response in individuals with rheumatoid arthritis (Dervieux
et al. 2004a).
In summary, our study has provided a comparative
analysis of functional variants on key enzymes in the folate
and homocysteine metabolic pathway in an admixed pop-
ulation consisting of 1,350 Mexican males and females. By
including three Amerindian groups and publicly available
data from European, African and East Asian populations,
we could provide explanation for the differential distribu-
tion of the risk genotypes in Mexico and show their
worldwide frequency overview. Our results showed that
highly frequent risk variants have population-specific dis-
tributions, potentially resulting from either selective pres-
sure or genetic drift. Incorporating these results together
with other worldwide reports on folate pathway-related
SNPs and dietary exposures could contribute in under-
standing the progression and prevalence of relevant disor-
ders. Finally, the potential role of some of these variants in
conferring genetic risk to public health relevant disorders
and traits warrants that these results are considered for
public health policy making and to strengthen preventive
strategies to improve the definition of specific dietary
requirements in relevant populations.
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